NuCana plc
NCNANASDAQHealthcareBiotechnology
As of Oct 16, 2026 close
- Market cap
- $4.27M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.95$6.10
- Volume (live)
- -
- Avg. volume (3M)
- 77.08K
NuCana (NCNA) Stock Price & Financial Analysis
NuCana Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.97 - $1.03 |
|---|---|
| 52-Week High | $6.10 |
| 52-Week Low | $0.95 |
| Open | $1.02 |
| Volume (last close) | 46.27K |
| Average Volume (3M) | 77.08K |
| 50-Day MA | $1.35 |
|---|---|
| 200-Day MA | $1.90 |
| 1-Year Change | −79.88% |
| Market Cap | 4.27M |
|---|---|
| Shares Outstanding | 4.19M |
| Price to Book (P/B) | 0.16 |
| EV/EBITDA | 1.09 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
NuCana at a Glance
As of the Oct 16, 2026 close, NuCana (NCNA) has a market capitalization of $4.27M.
As of its latest reported balance sheet, it holds $26.00M in cash and securities against $890.57K of debt, a net cash position of $25.10M.
NuCana does not currently pay a dividend.
The share price is down 79.9% over the past year. At $0.99 (the Oct 16, 2026 close) it sits near the bottom of its 52-week range of $0.95 to $6.10, below its 200-day moving average of $1.90.
Frequently Asked Questions About NuCana
What is the current stock price for NCNA?
As of the Oct 16, 2026 close, NCNA stock trades at $0.99. The 52-week range is $0.95–$6.10, with a day range of $0.97–$1.03.
What is the P/E ratio for NCNA?
The P/E ratio (Price-to-Earnings) for NCNA is shown in the Key Statistics section. This valuation metric helps compare NuCana plc to industry peers.
Does NCNA pay dividends?
NuCana does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for NCNA?
Analyst ratings and recommendations for NCNA are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of NCNA?
As of the Oct 16, 2026 close, NuCana's market capitalization is $4.1M, classifying it as a micro-cap company. NuCana operates in the Healthcare sector within the Biotechnology industry.